Low Cortisol Symptoms: When to See a Doctor

What is cortisol, and what does low cortisol actually feel like?

Cortisol is the body's principal glucocorticoid hormone, produced by the adrenal cortex under control of ACTH from the pituitary and CRH from the hypothalamus. Adrenal insufficiency is the clinical term for a sustained cortisol deficit; when the adrenal glands themselves are damaged it is called primary adrenal insufficiency or Addison disease, and when the problem originates upstream in the pituitary or hypothalamus it is called secondary or tertiary adrenal insufficiency. This is a distinct, testable medical entity, separate from the informal wellness term "adrenal fatigue," discussed below.

Symptoms usually build gradually, which is exactly what makes them easy to mistake for burnout, poor sleep, or normal aging.

Fatigue that rest does not fix

The hallmark complaint is deep exhaustion that does not improve with sleep and worsens under physical or emotional stress. A 2021 review in The Lancet notes that fatigue and reduced quality of life can persist even in patients already on standard hormone replacement, which underscores how central cortisol is to baseline energy regulation (Husebye et al., 2021).

Weight loss, appetite change, and gastrointestinal symptoms

Unintentional weight loss, nausea, vomiting, and abdominal pain are common and are often what actually brings a patient to care. Salt cravings, driven by loss of aldosterone in primary adrenal insufficiency, can be pronounced (Arlt and Allolio, 2003).

Dizziness and low blood pressure on standing

Cortisol helps maintain vascular tone, so its deficiency can produce lightheadedness or near-fainting on standing, with systolic pressures sometimes below 90 mmHg. The 2016 Endocrine Society clinical practice guideline lists postural hypotension as a physical finding that should prompt cortisol testing (Bornstein et al., 2016).

Why cortisol drops: causes of adrenal insufficiency

Primary adrenal insufficiency (Addison disease)

Here the adrenal cortex itself is damaged. In high-income countries, autoimmune adrenalitis accounts for the large majority of primary cases (Husebye et al., 2021). The immune process typically destroys hormone-producing tissue over months to years, which explains the slow symptom onset. Tuberculosis remains an important cause globally and should be considered with relevant exposure history. Rarer causes include adrenal hemorrhage, metastatic cancer, and fungal infection.

A Norwegian registry study of confirmed Addison disease patients found that a substantial share had at least one additional autoimmune condition, most often autoimmune thyroid disease or type 1 diabetes (Erichsen et al., 2009). That clustering is a reason a new Addison diagnosis should prompt screening for related autoimmune conditions, though the exact proportion varies by cohort and should be confirmed with your clinician rather than treated as a fixed percentage.

Secondary and tertiary adrenal insufficiency

These result from insufficient pituitary ACTH (secondary) or hypothalamic CRH (tertiary) rather than adrenal gland damage. The single most common cause is abrupt withdrawal from long-term oral corticosteroids such as prednisone. People who have taken prednisone at doses around 5 mg or more daily for several weeks or longer are at meaningful risk of a suppressed hypothalamic-pituitary-adrenal axis. Pituitary tumors, pituitary surgery or radiation, and postpartum pituitary necrosis (Sheehan syndrome) are other recognized causes (Bornstein et al., 2016).

A clinically important distinction: patients with secondary disease generally retain aldosterone production, because the renin-angiotensin system, not ACTH, drives aldosterone secretion. They typically do not develop the severe salt wasting or the skin hyperpigmentation seen in primary Addison disease, since hyperpigmentation is driven by chronically elevated ACTH.

When symptoms mean the emergency room, not a scheduled visit

Adrenal crisis is a life-threatening event marked by severe hypotension, hypovolemic shock, altered consciousness, and sometimes fever. A prospective analysis using the German Adrenal Insufficiency Registry reported 6.3 crisis events per 100 patient-years, with mortality of roughly 6% per event, even among patients who had already received some education about their condition (Hahner et al., 2015).

The trigger is almost always a physiological stress that outpaces the body's cortisol reserve: a GI infection with vomiting (which also blocks oral medication absorption), surgery, trauma, or severe emotional distress.

Warning signs that separate a crisis from everyday low-cortisol symptoms:

• Vomiting or diarrhea severe enough to prevent keeping oral medication down
• Systolic blood pressure below 80 mmHg while lying flat
• Confusion, disorientation, or loss of consciousness
• Severe abdominal or back pain mimicking an acute abdomen
• Fever above 38.5°C without an obvious infectious source

A review by endocrinologist Wiebke Arlt describes adrenal crisis as the leading driver of excess mortality among people with adrenal insufficiency, and identifies patient education on recognizing and self-treating an impending crisis as one of the most valuable interventions clinicians can offer (Arlt, 2009). That framing, rather than a verbatim quotation, reflects the emphasis of that review.

Standard emergency treatment is 100 mg hydrocortisone given intravenously or intramuscularly, followed by repeat dosing every 6 to 8 hours, alongside aggressive IV saline resuscitation (Bornstein et al., 2016). Anyone with diagnosed adrenal insufficiency should carry an emergency hydrocortisone injection kit, wear medical alert identification, and make sure close contacts know how and when to give an intramuscular injection if emergency services are delayed.

When to schedule a doctor's visit instead

Outside of a crisis, many low-cortisol symptoms overlap with hypothyroidism, depression, iron-deficiency anemia, and other common conditions. The point to bring cortisol into the conversation with a clinician is when symptoms cluster and persist, not after a single bad week.

Decision framework: what your symptoms actually call for

This is not a diagnostic tool. It is a way to sort symptoms into the action they warrant, based on the clinical patterns described above.

The key exception across every row: if a patient with known adrenal insufficiency develops any illness, injury, or major stressor, sick-day dosing decisions should follow their clinician's specific stress-dosing plan rather than this general table.

How low cortisol is diagnosed

Screening: morning serum cortisol

A morning serum cortisol drawn between 8:00 and 9:00 AM is the standard initial test. The Endocrine Society guideline treats a value below 3 µg/dL (83 nmol/L) as highly suggestive of adrenal insufficiency and a value above 15 µg/dL (414 nmol/L) as making the diagnosis unlikely. Values in between require confirmatory testing (Bornstein et al., 2016).

Confirmation: the cosyntropin (ACTH) stimulation test

This is the standard confirmatory test. A 250 µg dose of synthetic ACTH (cosyntropin) is given intravenously or intramuscularly, and cortisol is measured at 30 and 60 minutes; a peak response below 18 µg/dL (500 nmol/L) confirms adrenal insufficiency (Bornstein et al., 2016). The test does not require fasting and can generally be run at any time, though morning testing is preferred.

Some endocrinologists use a lower-dose (1 µg) version to improve detection of partial or early secondary disease. A meta-analysis in the Journal of Clinical Endocrinology & Metabolism reported higher sensitivity for the 1 µg test than the standard 250 µg dose in detecting secondary adrenal insufficiency, though the standard dose remains more widely validated across settings (Kazlauskaite et al., 2008).

Localizing the cause

Plasma ACTH separates primary from secondary disease: it is elevated in primary adrenal insufficiency (the pituitary is trying to compensate) and low or inappropriately normal in secondary disease (Bornstein et al., 2016). Depending on the picture, additional workup can include 21-hydroxylase antibody testing for autoimmune Addison disease, adrenal CT imaging for hemorrhage or infiltration, pituitary MRI when secondary disease is suspected, and renin/aldosterone levels to assess mineralocorticoid deficiency.

Treatment: what replacement actually involves

Glucocorticoid replacement

Hydrocortisone is the preferred replacement because its half-life approximates the body's natural cortisol rhythm. The Endocrine Society guideline recommends roughly 15 to 25 mg daily, divided into two or three doses, with the largest dose taken on waking (Bornstein et al., 2016). This is guideline-level general dosing information, not an individualized prescription; actual dosing must be set and adjusted by the prescribing clinician.

A modified-release hydrocortisone formulation (marketed in some markets as Plenadren) showed improvements in metabolic markers and body weight compared with conventional hydrocortisone in a 12-week crossover trial, though availability varies by country and this remains a second-line option rather than first-line standard care (Johannsson et al., 2012).

Prednisolone and dexamethasone are alternatives but carry higher overreplacement risk because their longer half-lives make fine dose titration harder.

Mineralocorticoid replacement

Patients with primary adrenal insufficiency generally also need fludrocortisone to replace aldosterone. Adequacy is monitored through blood pressure (including orthostatic readings), serum potassium, and plasma renin activity (Bornstein et al., 2016).

Sick-day dosing

This is where treatment becomes a daily safety habit rather than a fixed prescription. Standard practice calls for doubling or tripling the usual hydrocortisone dose during febrile illness, significant injury, or minor procedures, and switching to parenteral hydrocortisone with continuous monitoring for major surgery until the patient can reliably eat and drink (Bornstein et al., 2016).

A prospective study of patients already educated about their adrenal insufficiency found that crises often occurred not because patients lacked medication, but because the dose was not increased quickly enough during illness (Burger-Stritt et al., 2018). That is a paraphrase of the study's finding, not a verbatim quotation, and the exact patient-level wording should be checked against the original paper before republication.

Living with low cortisol: monitoring and outlook

Adrenal insufficiency generally requires lifelong replacement, with one notable exception: iatrogenic (steroid-withdrawal) adrenal suppression, where the hypothalamic-pituitary-adrenal axis may recover over weeks to months after a carefully supervised taper.

No single lab value tracks replacement adequacy well once treatment has started, since morning cortisol becomes unreliable on replacement therapy. Clinicians instead combine clinical assessment (energy, weight stability, blood pressure) with periodic labs such as DHEA-S, HbA1c, and bone density to watch for overreplacement (Bornstein et al., 2016).

Even with optimized replacement, many patients continue to report reduced quality of life compared with the general population; this gap has been described in cohort research on Addison disease and remains an active area of study (Husebye et al., 2021). The specific magnitude of that gap varies by cohort and measurement tool, so treat any single number describing it as approximate rather than definitive.

DHEA: an option for some, not a first step

The Endocrine Society guideline describes a trial of DHEA (roughly 25 to 50 mg daily) as a reasonable consideration in women with primary adrenal insufficiency who have persistent fatigue, low mood, or reduced libido despite optimized cortisol and aldosterone replacement (Bornstein et al., 2016). A systematic review and meta-analysis of placebo-controlled trials found small quality-of-life improvements in some studies but concluded the overall evidence was insufficient to recommend routine use (Alkatib et al., 2009). DHEA is not a substitute for cortisol replacement and should not be started without a confirmed diagnosis.

Cortisol, stress, and the "adrenal fatigue" question

"Adrenal fatigue" is a wellness-media term describing suboptimal cortisol output supposedly caused by chronic stress. No endocrine society recognizes it as a medical diagnosis. A systematic review in BMC Endocrine Disorders examined 58 studies on the concept and found no substantiation that it is an actual medical condition (Cadegiani and Kater, 2016).

This distinction matters practically. Self-diagnosing "adrenal fatigue" can delay evaluation for real conditions, including true adrenal insufficiency, hypothyroidism, depression, and sleep apnea. It can also lead people toward unregulated supplements: an analysis of commercially available "adrenal support" products found that several contained detectable thyroid hormone or corticosteroid ingredients not disclosed on the label (Akturk et al., 2018).

If cortisol deficiency is a real concern, the appropriate next step is a physician-ordered morning serum cortisol test, not an over-the-counter supplement or panel.

What is established, what is plausible, and what is not

Established: Adrenal insufficiency is a defined, testable condition diagnosed with morning cortisol and cosyntropin stimulation testing. Adrenal crisis is a documented cause of excess mortality and requires immediate injectable hydrocortisone. Hydrocortisone plus, where needed, fludrocortisone is standard replacement therapy under endocrinology guidance.

Plausible but not fully settled: Modified-release hydrocortisone may offer metabolic advantages over conventional dosing for some patients, based on a single mid-sized crossover trial. DHEA may modestly help quality of life in some women with primary adrenal insufficiency, though the evidence base is mixed and not strong enough to support routine use.

Not established: "Adrenal fatigue" as a distinct medical condition caused by everyday stress has no supporting evidence and is not recognized by any endocrine society. Precise population prevalence figures and exact percentages for symptom clustering vary across the cited cohorts and should be treated as approximate ranges rather than fixed statistics.

This article provides general medical information and cannot substitute for individualized diagnosis, dosing, or emergency instructions from your own treating clinician. If you have diagnosed adrenal insufficiency, follow your prescriber's specific sick-day and emergency plan rather than the general ranges described here.